Product
Supplier
Encyclopedia
Inquiry
Home > Active Pharmaceutical Ingredients > Antineoplastic Agents > Topotecan hydrochloride for Sale > High Quality Anti-Tumor Raw Powder Topotecan Hydrochloride CAS 119413-54-6
High Quality Anti-Tumor Raw Powder Topotecan Hydrochloride CAS 119413-54-6 buy - large image1
High Quality Anti-Tumor Raw Powder Topotecan Hydrochloride CAS 119413-54-6 buy - image1

High Quality Anti-Tumor Raw Powder Topotecan Hydrochloride CAS 119413-54-6

GMP HALAL KOSHER ISO FDA

Unit Price: Get Latest Price
CAS No.:

119413-54-6

Grade:

Pharmaceutical Grade

Content:

99.9%

Packaging:

Foil Bag, Box, Drum

Price valid (until):

2022-12-31

Company Type:
Manufactory
Location:
China
Qualification:
Main Products:

Herb Extracts,Cosmetic raw materails,API

  • Product Description

  • Seller Information

  • Description




    Product Name Topotecan hydrochloride
    CAS No. 119413-54-6
    Molecular Formula C23H24ClN3O5
    Molecular Weight 457.91
    EINECS No. 1308068-626-2
    Melting point 213-218°C
    Boiling point 782.9ºC at 760mmHg
    Flash point 427.3ºC
    Steam pressure 8.13E-26mmHg at 25°C
    PSA 104.89000
    LogP 2.64880
    Refractive index 1.733
    Appearance White Powder
    Purity 99%
    Quality Standard Enterprise standard
    Storage Conditions Refrigerator
    Packing 1kg/foil bag;25kg/drum
    Shipment EMS;DHL;FedEx;TNT;UPS
    Delivery Time 4-7 Working Days
    Payment terms T/T;Western Union;Money Gram;Bitcoin
    Usage The best drugs for the treatment of ovarian cancer at present; Treatment of breast cancer, rectal cancer, colon cancer, acute and chronic white blood cell disease; used as anti-tumor drugs



    Topotecan hydrochloride is a water-soluble derivative of camptothecin, which is the form of hydrochloride of topotecan. It is successfully developed by the SmithKline Beecham US company, and approved by the FDA in the United States in 1996. Its trade name is Hycamtin. It is applied in the treatment of ovarian cancer (OVC) as the second-line therapy.

    In 1999 the US Food and Drug Administration (FDA) has approved topotecan hydrochloride as small cell lung cancer (SCLC) therapeutic drug. It has been available in the UK, Germany, France and other dozens of countries and regions. The 3 clinical trials are ongoing for this medicine which is used to treat non-small cell lung cancer, cervical cancer, myelodysplastic syndrome.

    Topotecan hydrochloride can enter the blood brain barrier. It has the same effect of oral and intravenous injection. The drug has low toxicity predictable bone marrow suppression, and other minor non-hematologic toxicity. Currently there are manufacturers, for clinical treatment of small cell lung cancer, ovarian cancer and other tumors.

    Topotecan hydrochloride inhibits the activity of topoisomerase I, which is required for DNA replication. After intravenous injection, the product is hydrolyzed in the blood, and excreted by urinary. This product has a rapid serum clearance rate, which is 62L/h. It is widely distributed in vivo, and Its half-lifetime is about 2~3h. Preclinical trials have shown that the product has anti-tumor activity on all kinds of types of tumor. In I clinical trial, to patients with ovarian cancer that is cisplatin tolerance, this product also has significant anti-tumor effect.


    Certificates

    Basic Info
    Product Name:

    Topotecan hydrochloride

    Other Name:

    1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-,hydrochloride (1:1),(4S)-;1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-,monohydrochloride,(S)-;1H-Pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione,10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-,monohydrochloride,(4S)-;SKF 104864A;NSC 609669;Topotecan hydrochloride;Hycamtin;SKFS 104864A;Nogitecan hydrochloride;Topotecan chlorohydrate;(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3′,4′:6,7]indolizino[l,2-b]quinoline-3,14(4H,12H)-dione monohydrochloride;Xinze

    CAS No.:

    119413-54-6

    Molecular Formula:

    C23H23N3O5.ClH

    InChIKeys:

    InChIKey=DGHHQBMTXTWTJV-BQAIUKQQSA-N

    Molecular Weight:

    457.91

    Exact Mass:

    421.163757

    EC Number:

    1308068-626-2

    UNII:

    956S425ZCY

    NSC Number:

    759263|609699

    DSSTox ID:

    DTXSID1045952

    NCI Thesaurus Code:

    C2828

    ATC Code:

    L01CE01

    HScode:

    29420000

    Categories:

    Antineoplastic Agents

    Characteristics
    PSA:

    103

    XLogP3:

    2.64880

    Appearance:

    White Crystalline Solid

    Density:

    1.5±0.1 g/cm3

    Melting Point:

    215 °C (decomp)

    Boiling Point:

    782.9ºC at 760mmHg

    Flash Point:

    427.3±32.9 °C

    Refractive Index:

    1.734

    Storage Conditions:

    Refrigerator

    Vapor Pressure:

    8.13E-26mmHg at 25°C

    Collision Cross Section:

    211.2 Ų [M+H]+ [CCS Type: TW, Method: calibrated with polyalanine and drug standards]

    Hazard Identification

    Classification of the substance or mixture

    Germ cell mutagenicity, Category 1B

    Carcinogenicity, Category 2

    Reproductive toxicity, Category 2

    GHS label elements, including precautionary statements

    Pictogram(s)
    Signal word

    Danger

    Hazard statement(s)

    H340 May cause genetic defects

    H351 Suspected of causing cancer

    H361 Suspected of damaging fertility or the unborn child

    Precautionary statement(s)
    Prevention

    P203 Obtain, read and follow all safety instructions before use.

    P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...

    Response

    P318 IF exposed or concerned, get medical advice.

    Storage

    P405 Store locked up.

    Disposal

    P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Manufactory

    Main Products:

    Herb Extracts,Cosmetic raw materails,API

    Location:

    1403,Jinye B Block

    Payment Terms:

    TT against copy of documents

    Average lead Time:

    8

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    11-50

    Year of Establishment:

    2015

    Xian ZB Biotech Co.,Ltd is a leading Manufactory supplier of Arbutin, Nicotinamide, Flucytosine based in Xi'an, Shaanxi, China. With a commitment to quality and customer satisfaction, Xian ZB Biotech Co.,Ltd has become a trusted name in the industry. Our product line includes a range of high-quality Arbutin, Nicotinamide, Flucytosine, which are available at competitive prices. Xian ZB Biotech Co.,Ltd has established itself as a reliable supplier of chemical products on the echemi.com.

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.